Real-time dissolution behavior of furosemide in biorelevant media as determined by UV imaging

References

• Benet LZ, Broccatelli F, Oprea TI. BDDCS applied to over 900 drugs. AAPS J 2011;13:519–547.
   PubMed Web of Science ®Google Scholar
• Broccatelli F, Cruciani G, Benet LZ, Oprea TI. BDDCS class prediction for new molecular entities. Mol Pharm 2012;9:570–580.
   PubMed Web of Science ®Google Scholar
• Lipinski CA. Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 2000;44:235–249.
   PubMed Web of Science ®Google Scholar
• Miyake M, Minami T, Toguchi H, Odomi M, Ogawara K, Higaki K et al. Importance of bile acids for novel oral absorption system containing polyamines to improve intestinal absorption. J Control Release 2006;115:130–133.
   PubMed Web of Science ®Google Scholar
• Dokoumetzidis A, Macheras P. A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. Int J Pharm 2006;321:1–11.
   PubMed Web of Science ®Google Scholar
• Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12:413–420.
   PubMed Web of Science ®Google Scholar
• Tsume Y, Amidon GL. The biowaiver extension for BCS class III drugs: the effect of dissolution rate on the bioequivalence of BCS class III immediate-release drugs predicted by computer simulation. Mol Pharm 2010;7:1235–1243.
   PubMed Web of Science ®Google Scholar
• McAllister M. Dynamic dissolution: A step closer to predictive dissolution testing? Mol Pharm 2010;7:1374–1387.
   PubMed Web of Science ®Google Scholar
• Kleberg K, Jacobsen J, Müllertz A. Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies. J Pharm Pharmacol 2010;62:1656–1668.
   PubMed Web of Science ®Google Scholar
• Klein S. The use of biorelevant dissolution media to forecast the in vivo performance of a drug. AAPS J 2010;12:397–406.
   PubMed Web of Science ®Google Scholar
• Dressman JB, Amidon GL, Reppas C, Shah VP. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm Res 1998;15:11–22.
   PubMed Web of Science ®Google Scholar
• Hörter D, Dressman JB. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev 2001;46:75–87.
   PubMed Web of Science ®Google Scholar
• Neervannan S, Dias LS, Southard MZ, Stella VJ. A convective-diffusion model for dissolution of two non-interacting drug mixtures from co-compressed slabs under laminar hydrodynamic conditions. Pharm Res 1994;11:1288–1295.
   PubMedGoogle Scholar
• Greco K, Bergman TL, Bogner R. Design and characterization of a laminar flow-through dissolution apparatus: Comparison of hydrodynamic conditions to those of common dissolution techniques. Pharm Dev Technol 2011;16:75–87.
   PubMed Web of Science ®Google Scholar
• Peltonen L, Liljeroth P, Heikkilä T, Kontturi K, Hirvonen J. Dissolution testing of acetylsalicylic acid by a channel flow method-correlation to USP basket and intrinsic dissolution methods. Eur J Pharm Sci 2003;19:395–401.
   PubMed Web of Science ®Google Scholar
• Neervannan S, Reinert JD, Stella VJ, Southard MZ. A numerical convective-diffusion model for dissolution of neutral compounds under laminar flow conditions. Int J Pharm 1993;96:167–174.
   Web of Science ®Google Scholar
• Shah AC, Nelson KG. Evaluation of a convective diffusion drug dissolution rate model. J Pharm Sci 1975;64:1518–1520.
   PubMed Web of Science ®Google Scholar
• Compton RG, Harding MS, Pluck MR, Atherton JH, Brennan CM. Mechanism of solid/liquid interfacial reactions: the dissolution of benzoic acid in aqueous solution. J Phys Chem 1993;97:10416–10420.
   Google Scholar
• Wilkins SJ, Compton RG, Taylor MA, Viles HA. Channel Flow Cell Studies of the Inhibiting Action of Gypsum on the Dissolution Kinetics of Calcite: A Laboratory Approach with Implications for Field Monitoring. J Colloid Interface Sci 2001;236:354–361.
   PubMedGoogle Scholar
• Lehto P, Aaltonen J, Niemelä P, Rantanen J, Hirvonen J, Tanninen VP et al. Simultaneous measurement of liquid-phase and solid-phase transformation kinetics in rotating disc and channel flow cell dissolution devices. Int J Pharm 2008;363:66–72.
   PubMedGoogle Scholar
• Aaltonen J, Heinänen P, Peltonen L, Kortejärvi H, Tanninen VP, Christiansen L et al. In situ measurement of solvent-mediated phase transformations during dissolution testing. J Pharm Sci 2006;95:2730–2737.
   PubMedGoogle Scholar
• van der Weerd J, Kazarian SG. Release of poorly soluble drugs from HPMC tablets studied by FTIR imaging and flow-through dissolution tests. J Pharm Sci 2005;94:2096–2109.
   PubMed Web of Science ®Google Scholar
• Fyfe CA, Grondey H, Blazek-Welsh AI, Chopra SK, Fahie BJ. NMR imaging investigations of drug delivery devices using a flow-through USP dissolution apparatus. J Control Release 2000;68:73–83.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Gladden L, Avalle P, Mantle M. In vitro quantitative ((1))H and ((19))F nuclear magnetic resonance spectroscopy and imaging studies of fluvastatin™ in Lescol® XL tablets in a USP-IV dissolution cell. J Control Release 2011;156:345–354.
   PubMed Web of Science ®Google Scholar
• Kazarian SG, van der Weerd J. Simultaneous FTIR spectroscopic imaging and visible photography to monitor tablet dissolution and drug release. Pharm Res 2008;25:853–860.
   PubMed Web of Science ®Google Scholar
• Wray PS, Clarke GS, Kazarian SG. Application of FTIR spectroscopic imaging to study the effects of modifying the pH microenvironment on the dissolution of ibuprofen from HPMC matrices. J Pharm Sci 2011;100:4745–4755.
   PubMed Web of Science ®Google Scholar
• Richardson JC, Bowtell RW, Mäder K, Melia CD. Pharmaceutical applications of magnetic resonance imaging (MRI). Adv Drug Deliv Rev 2005;57:1191–1209.
   PubMed Web of Science ®Google Scholar
• Nott KP. Magnetic resonance imaging of tablet dissolution. Eur J Pharm Biopharm 2010;74:78–83.
   PubMed Web of Science ®Google Scholar
• Mantle MD. Quantitative magnetic resonance micro-imaging methods for pharmaceutical research. Int J Pharm 2011;417:173–195.
   PubMedGoogle Scholar
• Reich G. Near-infrared spectroscopy and imaging: basic principles and pharmaceutical applications. Adv Drug Deliv Rev 2005;57:1109–1143.
   PubMed Web of Science ®Google Scholar
• Metz H, Mäder K. Benchtop-NMR and MRI–a new analytical tool in drug delivery research. Int J Pharm 2008;364:170–175.
   PubMed Web of Science ®Google Scholar
• Boetker JP, Savolainen M, Koradia V, Tian F, Rades T, Müllertz A et al. Insights into the early dissolution events of amlodipine using UV imaging and Raman spectroscopy. Mol Pharm 2011;8:1372–1380.
   PubMedGoogle Scholar
• Ye F, Yaghmur A, Jensen H, Larsen SW, Larsen C, Østergaard J. Real-time UV imaging of drug diffusion and release from Pluronic F127 hydrogels. Eur J Pharm Sci 2011;43:236–243.
   PubMed Web of Science ®Google Scholar
• Østergaard J, Meng-Lund E, Larsen SW, Larsen C, Petersson K, Lenke J et al. Real-time UV imaging of nicotine release from transdermal patch. Pharm Res 2010;27:2614–2623.
   PubMed Web of Science ®Google Scholar
• Østergaard J, Ye F, Rantanen J, Yaghmur A, Larsen SW, Larsen C et al. Monitoring lidocaine single-crystal dissolution by ultraviolet imaging. J Pharm Sci 2011;100:3405–3410.
   PubMed Web of Science ®Google Scholar
• Hulse WL, Gray J, Forbes RT. A discriminatory intrinsic dissolution study using UV area imaging analysis to gain additional insights into the dissolution behaviour of active pharmaceutical ingredients. Int J Pharm 2012;434:133–139.
   PubMedGoogle Scholar
• Pajander J, Baldursdottir S, Rantanen J, Ostergaard J. Behaviour of HPMC compacts investigated using UV-imaging. Int J Pharm 2012;427:345–353.
   PubMed Web of Science ®Google Scholar
• Avdeef A, Tsinman O. Miniaturized rotating disk intrinsic dissolution rate measurement: effects of buffer capacity in comparisons to traditional wood’s apparatus. Pharm Res 2008;25:2613–2627.
   PubMed Web of Science ®Google Scholar
• Avdeef A, Berger CM, Brownell C. pH-metric solubility. 2: correlation between the acid-base titration and the saturation shake-flask solubility-pH methods. Pharm Res 2000;17:85–89.
   PubMed Web of Science ®Google Scholar
• Grahnén A, Hammarlund M, Lundqvist T. Implications of intraindividual variability in bioavailability studies of furosemide. Eur J Clin Pharmacol 1984;27:595–602.
   PubMedGoogle Scholar
• Granero GE, Longhi MR, Mora MJ, Junginger HE, Midha KK, Shah VP et al. Biowaiver monographs for immediate release solid oral dosage forms: furosemide. J Pharm Sci 2010;99:2544–2556.
   PubMed Web of Science ®Google Scholar
• Lee MG, Chiou WL. Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism. J Pharmacokinet Biopharm 1983;11:623–640.
   PubMedGoogle Scholar
• Missel PJ, Stevens LE, Mauger JW. Reexamination of convective diffusion/drug dissolution in a laminar flow channel: accurate prediction of dissolution rate. Pharm Res 2004;21:2300–2306.
   PubMed Web of Science ®Google Scholar
• Matsuda Y, Tatsumi E. Physicochemical characterization of furosemide modifications. Int J Pharm 1990;60:11–26.
   Web of Science ®Google Scholar
• Allen FH. The Cambridge Structural Database: a quarter of a million crystal structures and rising. Acta Crystallogr, B 2002;58:380–388.
   PubMed Web of Science ®Google Scholar
• Lamotte PJ, Campsteyn H, Dupont L, Vermeire M. Structure cristalline et moléculaire de l’acide furfurylamino-2 chloro-4 sulfamoyl-5 benzoïque, la furosémide (C12H11ClN2O5S). Acta Cryst 1978;34:1657–1661.
   Web of Science ®Google Scholar
• Sassene PJ, Knopp MM, Hesselkilde JZ, Koradia V, Larsen A, Rades T et al. Precipitation of a poorly soluble model drug during in vitro lipolysis: characterization and dissolution of the precipitate. J Pharm Sci 2010;99:4982–4991.
   PubMed Web of Science ®Google Scholar
• Lehto P, Aaltonen J, Tenho M, Rantanen J, Hirvonen J, Tanninen VP et al. Solvent-mediated solid phase transformations of carbamazepine: Effects of simulated intestinal fluid and fasted state simulated intestinal fluid. J Pharm Sci 2009;98:985–996.
   PubMed Web of Science ®Google Scholar